In these comments on the Buprenorphine via Telemedicine Proposed Rule, NHeLP urges the DEA to withdraw the proposed rule related to the induction of buprenorphine via telemedicine and continue the expanded telemedicine flexibilities under the Opioid Public Health Emergency.
Since 1986, the Advocate's Guide to the Medicaid Program has been the leading authoritative reference on Medicaid law. Pre-order today to reserve your copy of the 5th edition. The Guide is available in both print and digital versions, which will be available this fall.